Mehmet Yumru

Mehmet Yumru

Auto-generated profile, based on publicly available information

Mehmet Yumru

Psychiatry Department, Gaziantep University, Medical Faculty, Gaziantep, Turkey

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2007 in Archives of Medical Research
Verified
Journal Article
Closed access
HHHasan Herken
Hasan Herken
AGAhmet Gurel
Ahmet Gurel
SSSalih Selek
Salih Selek
FAFerah Armutcu
Ferah Armutcu
MOMurat Eren Ozen
Murat Eren Ozen
OAOmer Akyol
Omer Akyol

1 April 2008 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SSSalih Selek
Salih Selek
HSHaluk A. Savas
Haluk A. Savas
HGH. Serdar Gergerlioglu
H. Serdar Gergerlioglu
FBFeridun Bulbul
Feridun Bulbul
EUEfkan Uz
Efkan Uz
MYMehmet Yumru
Mehmet Yumru

1 August 2009 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
MYMehmet Yumru
Mehmet Yumru
HSHaluk A. Savas
Haluk A. Savas
AKAysun Kalenderoglu
Aysun Kalenderoglu
MBMahmut Bulut
Mahmut Bulut
HCHakim Celik
Hakim Celik
OEOzcan Erel
Ozcan Erel

1 March 2007 in Journal of Affective Disorders
Verified
Journal Article
Closed access
MYMehmet Yumru
Mehmet Yumru
HSHaluk A. Savas
Haluk A. Savas
EKErhan Kurt
Erhan Kurt
MKM. Cemal Kaya
M. Cemal Kaya
SSSalih Selek
Salih Selek
MAMurat İlhan Atagün
Murat İlhan Atagün

1 April 2007 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
HGH. Serdar Gergerlioglu
H. Serdar Gergerlioglu
HSHaluk A. Savas
Haluk A. Savas
FBFeridun Bulbul
Feridun Bulbul
SSSalih Selek
Salih Selek
EUEfkan Uz
Efkan Uz
MYMehmet Yumru
Mehmet Yumru

21 September 2009 in Neuropsychobiology
Verified
Journal Article
Closed access
PDF file
OVOsman Virit
Osman Virit
AAAbdurrahman Altindag
Abdurrahman Altindag
MYMehmet Yumru
Mehmet Yumru
ADAlican Dalkilic
Alican Dalkilic
HSHaluk Asuman Savas
Haluk Asuman Savas
HHHasan Herken
Hasan Herken
Objectives: Several oxidants and antioxidants have been evaluated in schizophrenia. However, previous studies frequently focused on individual parameters. Determination of the total oxidant and antioxidant status may be more useful. Therefore, we aimed to evaluate both plasma total oxidant status (TOS) and total antioxidant status (TAS) together with the oxidative stress index (OSI) in schizophrenia patients for the first time in the literature. Methods: A total of 60 schizophrenia patients and 40 healthy volunteers were included in the study. The Positive and Negative Syndrome Scale (PANSS) and the Clinical Global Impression-severity scale (CGI-S) were used to evaluate the severity of schizophrenia in the patients. TOS and TAS were measured in plasma and the OSI was calculated for patients and controls. Results: There was no difference between patients and controls with regard to TOS, but the patients’ TAS and OSI were significantly lower and higher, respectively, than those of the controls. No difference was detected between the schizophrenia subtypes or between the patients on typical or atypical antipsychotic medications or a combination of the two with regard to oxidative parameters. There was a weak to moderately significant negative correlation between TAS and total, positive and general psychopathology PANSS scores. Finally, we found a weak to moderately significant negative correlation between the CGI-S score and TOS and between the CGI-S score and TAS. Conclusions: There is a defect in the antioxidant defense system in schizophrenia. Known oxidative stress that causes oxidative cell damage and thus contributes to the pathophysiology of schizophrenia may be mainly related to this defensive defect.